KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2025)

Vir Biotechnology's Other Non Operating Income history spans 8 years, with the latest figure at -$335000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 33.79% to -$335000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$409000.0, a 81.58% increase, with the full-year FY2025 number at -$409000.0, up 81.58% from a year prior.
  • Other Non Operating Income hit -$335000.0 in Q4 2025 for Vir Biotechnology, down from -$228000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for VIR hit a ceiling of $27.0 million in Q3 2022 and a floor of -$26.2 million in Q4 2022.
  • Historically, Other Non Operating Income has averaged -$839900.0 across 5 years, with a median of -$257500.0 in 2024.
  • The widest YoY moves for Other Non Operating Income: up 42128.12% in 2022, down 374000.0% in 2022.
  • Tracing VIR's Other Non Operating Income over 5 years: stood at -$7000.0 in 2021, then tumbled by 374000.0% to -$26.2 million in 2022, then surged by 94.33% to -$1.5 million in 2023, then surged by 65.93% to -$506000.0 in 2024, then soared by 33.79% to -$335000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for VIR at -$335000.0 in Q4 2025, -$228000.0 in Q3 2025, and $226000.0 in Q2 2025.